跳至主要内容
临床试验/DRKS00014622
DRKS00014622进行中(未招募)未知

Impact of a multispecies probiotic on the intestinal microbiome during antibiotic treatment

nutrimmun GmbH0 个研究点目标入组 84 人开始时间: 2018年5月9日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
84

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • Main inclusion criteria: positive diagnosis of H. pylori infection based on results of gastroscopy / histology., Indication of Helicobacter eradication according to standard triple therapy (French) as a primary treatment for 7 days (1-0-1), men and women (at least 30% of each gender), age: 18 – 70 years, BMI: 18.5 – 30, written informed consent

排除标准

  • main exclusion Criteria:
  • Known inflammatory and malignant gastrointestinal diseases (i.e. colitis ulcerosa, Morbus Crohn, celiac disease, malignant diseases e.g. Colon-cancer, rectum cancer, pancreatitis), immune suppressed patients,Diabetes mellitus, regular intake of probiotics 4 weeks prior to and during the study, use of antibiotics (oral or i.v.) 3 months prior to study start, participation in another clinical study within the last 4 weeks and concurrent participation in another clinical study, women: known pregnancy, breast feeding or intention to become pregnant during the study

研究者

发起方
nutrimmun GmbH

相似试验